Ehab Atallah, MD
Medical College of Wisconsin
9
8
3
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+14 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (9)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Jorge Cortes, MD
M.D. Anderson Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Moshe Talpaz, MD
Univ. of Michigan Comprehensive Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
H.Jean Khoury, MD
Emory University
Shared therapeutic areas:
Worked with same sponsors:
Kathryn Flynn, PhD
Medical College of Wisconsin
Shared therapeutic areas:
Worked with same sponsors:
Michael J. Mauro, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Richard A Larson, MD
University of Chicago
Shared therapeutic areas:
Worked with same sponsors:
Hedy P Smith, MD
Tufts Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Javier Pinilla-Ibarz, MD,PhD
H. Lee Moffitt Cancer Center and Research Institute
Shared therapeutic areas:
Worked with same sponsors:
B. Douglas Smith, MD
Sidney Kimmel Cancer Center at Johns Hopkins
Shared therapeutic areas:
Worked with same sponsors:
David Snyder, M.D.
City of Hope Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Publications (0)
No publications found for this investigator.
Clinical Trials (9)
Showing 9 of 9 trials
XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia
Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)
The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)
Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial Treatment
All 9 trials loaded